Pravadoline

This classification denotes a cyclooxygenase inhibitor with the molecular formula C23H26N2O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier P3JW662TWA, chemically known as methanone, (4-methoxyphenyl)(2-methyl-1-(2-(4-morpholinyl)ethyl)-1h-indol-3-yl)- but generally known as pravadoline, which bears US NIH Compound Identifier 56463. European Medicines Agency schedules Pravadoline in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10003MIG. The term PRAVADOLINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 3, No. 3, 1989, List 29). PRAVADOLINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule pravadoline under HS 29349990 and SITC 51579. As of Q4 2014, PRAVADOLINE remains the US FDA Preferred Term for this commodity. Pravadoline bears US NLM identifiers UMLS ID C0071815 and NCI Concept Code C84104. SMILES: O1CCN(CCN2C3C(C(C2C)C(=O)C2CCC(OC)CC2)CCCC3)CC1.